Marius Pharmaceuticals Expands Access of KYZATREX™ (testosterone undecanoate) to Department of Veterans Affairs (VA), Pledging Support for Proper Hormonal Balance Among Military Personnel
September 19, 2023 09:30 ET
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, is proud to announce the...
Global Finasteride Market Analysis and Forecast Report 2023-2031: Growth Opportunities in Emerging Markets
September 08, 2023 09:43 ET
|
Research and Markets
Dublin, Sept. 08, 2023 (GLOBE NEWSWIRE) -- The "Finasteride Market By Application, By Type, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been...
Marius Pharmaceuticals Partners with Smartway to Design and Manage the global Early Access Program for KYZATREX™ (testosterone undecanoate)
August 10, 2023 09:30 ET
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals (Marius) and Smartway Pharmaceuticals (Smartway) are pleased to announce their strategic partnership, aimed at addressing the...
Product Innovation Boosts Growth of Testosterone Replacement Therapy Market, Projected to Reach $1.85 Billion in 2023
July 26, 2023 04:23 ET
|
Research and Markets
Dublin, July 26, 2023 (GLOBE NEWSWIRE) -- The "Testosterone Replacement Therapy Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides...
Marius Pharmaceuticals Announces Launch of ReThink Testosterone, Disease-State Awareness Initiative for Patients
July 24, 2023 09:00 ET
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., July 24, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a patient-centric healthcare company specializing in therapies for hypogonadism or Testosterone Deficiency, is proud to...
Global Hormone Therapy Market Set to Reach $23.65 Billion by 2027 with Growing Demand for Innovative Treatments and Rising Hormone Imbalance Cases
July 24, 2023 07:13 ET
|
Research and Markets
Dublin, July 24, 2023 (GLOBE NEWSWIRE) -- The "Hormone Therapy Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The market is projected to grow from $17.34...
Marius Pharmaceuticals Supports AXYS 2023 Virtual Family Conference, Spotlighting KYZATREX™ for XY Chromosome Variations, such as Klinefelter’s Syndrome
June 20, 2023 08:30 ET
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., June 20, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a patient-centric healthcare company specializing in therapies for hypogonadism or testosterone deficiency, announced today...
Marius Pharmaceuticals Announces Two Key Patents Related to KYZATREX™ in FDA Orange Book
June 09, 2023 10:00 ET
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., June 09, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a patient-centric healthcare company focused on therapies designed for hypogonadism or testosterone deficiency, announced...
Global Polycystic Ovary Syndrome Treatment Market Report 2023: Sector is Expected to Reach $1.5 Billion by 2030 at a CAGR of 4.9%
June 01, 2023 11:23 ET
|
Research and Markets
Dublin, June 01, 2023 (GLOBE NEWSWIRE) -- The "Polycystic Ovary Syndrome Treatment Market, By Drug Class, By Distribution Channel, By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 -...
HealthEd Academy Reports On The Latest Ketogenic Diet Study And Its Link To Boosting Testosterone By 25%
December 20, 2022 09:00 ET
|
HealthEd Academy
Clark, New Jersey, Dec. 20, 2022 (GLOBE NEWSWIRE) -- HealthEd Academy was created by fitness and bodybuilding expert, Steve Price, to share his vast experience and knowledge on how you can gain...